Search

EBI Food Safety claims it is taking a quantum leap in the fight against bacteria with the establishment of the first west European facility for industrial-scale production of bacteriophages.

What's hot for for 2006? Spin-outs and carve-outs, says senior Atlas Venture partner Christopher Spray in an interview for Science|Business

A Danish biopharmaceutical company and the University of Copenhagen, Denmark, have set up the MicroRNA Research Consortium, with funding from the Danish Advanced Technology Foundation.

Some large wave and tidal projects are now coming to fruition, but they will need to secure a premium price for the electricity they generate.

Searching for the best tax incentives in European R&D? Then look no further than the Science|Business guide to this popular - though by no means universal - stimulant.

Spend more on basic research - that's one of the prescriptions for Europe offered by Jim Goodnight, founder and CEO of SAS, one of the world's largest privately held software companies.

Inexpensive, fun applications can make a big splash in the consumer robotics market, but investors are waiting for a new 'killer app' before putting their money on the table.

Hailed as one of the most important recent discoveries in biology, RNA interference has seen patent applications rise 3,000 per cent between 2000 and 2003.

So far Italy has barely registered on the roster of biotech nations. Now that is set to change as the first biotechnology champions emerge and the country goes all out to attract inward investment.

Three new centres for systems biology are to be launched with funding of £27 million from the UK’s Biotechnology and Biological Sciences Research Council and the Engineering and Physical Sciences Research Council.

The Finnish developers of a virtual guitar are looking for investment to develop the technology and to bring it to public venues.

A spin-out from Oxford University is looking to attract the attention of equity investors and pharmaceutical companies by focusing on the discovery and development of small molecules to treat cancer

Researchers are taking cues from a century-old spray drying technology to see if it could be developed to make better products for the food and pharmaceutical industries. They are now looking for investors and partnership from industry players.

The inventors of an imaging system to improve diagnosis of coronary heart disease are looking at licensing the technology – or getting venture capital to create a spin-out.

A researcher at the Academic Medical Centre in Amsterdam has developed instruments that could assist surgeons to perform keyhole surgery. The centre is now looking for investors and partnership or licensing agreements for the technology.

The conclusion that there was nothing wrong with the specifics of the TeGenero trial in which six healthy volunteers ended up in intensive care has repercussions for the wider biotech industry.

The European Union's plan to transform Europe's drug discovery industry borrows some of its style from the US - but not everything.

Europe needs more "angel" investors to finance its start-ups. A Prague conference highlights why it isn't getting them.

What happens to the company labs when there’s a merger? That’s the question many in the telecoms industry are now asking, following news of merger plans by US-based Lucent and France's Alcatel.

While the telecommunications industry retrenches, the dominant French operator expands its research budget and seeks new lab partners. Why?